A detailed history of Metis Global Partners, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Metis Global Partners, LLC holds 2,444 shares of NBIX stock, worth $306,746. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,444
Previous 2,241 9.06%
Holding current value
$306,746
Previous $308,000 8.77%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$114.58 - $153.15 $23,259 - $31,089
203 Added 9.06%
2,444 $281,000
Q2 2024

Aug 06, 2024

BUY
$130.86 - $143.19 $3,925 - $4,295
30 Added 1.36%
2,241 $308,000
Q1 2024

May 06, 2024

SELL
$130.4 - $143.74 $2,477 - $2,731
-19 Reduced 0.85%
2,211 $304,000
Q4 2023

Feb 06, 2024

SELL
$106.07 - $132.76 $13,895 - $17,391
-131 Reduced 5.55%
2,230 $293,000
Q3 2023

Nov 07, 2023

BUY
$94.02 - $117.1 $9,966 - $12,412
106 Added 4.7%
2,361 $265,000
Q2 2023

Aug 07, 2023

BUY
$89.53 - $104.87 $15,757 - $18,457
176 Added 8.47%
2,255 $212,000
Q1 2023

May 08, 2023

BUY
$94.11 - $123.02 $195,654 - $255,758
2,079 New
2,079 $210,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Metis Global Partners, LLC Portfolio

Follow Metis Global Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.